Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62009TN0331

Case T -331/09: Action brought on 25 August 2009 — Novartis v OHIM — Sanochemia Pharmazeutika AG

OJ C 267, 7.11.2009, p. 70–71 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

7.11.2009   

EN

Official Journal of the European Union

C 267/70


Action brought on 25 August 2009 — Novartis v OHIM — Sanochemia Pharmazeutika AG

(Case T -331/09)

2009/C 267/128

Language in which the application was lodged: German

Parties

Applicant: Novartis AG (Basel, Switzerland) (represented by: N. Hebeis, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Other part to the proceedings before the Board of Appeal of OHIM: Sanochemia Pharmazeutika AG

Form of order sought

Annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 18 June 2009 in Case R 1601/2007-1; and

Order the Office for Harmonisation in the Internal Market to pay the costs.

Pleas in law and main arguments

Applicant for a Community trade mark: Sanochemia Pharmazeutika AG

Community trade mark concerned: the word mark, ‘TOLPOSAN’ for goods in Class 5 (Registration No 4 134 383)

Proprietor of the mark or sign cited in the opposition proceedings: the applicant

Mark or sign cited in opposition: the international registration of the word mark ‘TONOPAN’ for goods in Class 5 (No 227 508)

Decision of the Opposition Division: Opposition dismissed

Decision of the Board of Appeal: Appeal dismissed

Pleas in law: Infringement of Article 8(1)(b) of Regulation (EC) No 207/2009 (1), since there is no likelihood of confusion between the trade marks at issue.


(1)  Council Regulation (EC) No 207/2009 of 26 February 2009 on the Community trade mark (OJ 2009 L 78, p. 1).


Top
  翻译: